LOWER RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR: A REACH-B ANALYSIS OF THE ENUMERATE STUDY

被引：0
|
作者：
Ahn, J. [1 ]
Nguyen, M. [2 ]
Lee, H. [3 ]
Lim, J. [4 ]
Pan, C. [5 ]
Te, H. [6 ]
Tran, T. [7 ]
Trinh, H. N. [8 ]
Lau, D. [9 ]
Chu, D. [10 ]
Min, A. [11 ]
Leduc, T. -S. [12 ]
Pillai, A. [13 ]
Bae, H. [14 ]
Do, S. [15 ]
Mannalithara, A. [2 ]
Lok, A. S. [16 ]
Kim, W. R. [2 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Tufts Univ, Boston, MA 02111 USA
[4] Yale Univ, New Haven, CT USA
[5] NYU Langone, New York, NY USA
[6] Univ Chicago, Chicago, IL 60637 USA
[7] Cedars Sinai, Los Angeles, CA USA
[8] San Jose Gastroenterol, San Jose, CA USA
[9] Beth Israel Deaconess Med Ctr, Boston, MA USA
[10] Albert Einstein Coll Med, New York, NY USA
[11] Mt Sinai Beth Israel, New York, NY USA
[12] Leduc Med Grp Inc, Fountain Valley, CA USA
[13] Emory Univ, Atlanta, GA 30322 USA
[14] St Vincents Med Ctr, Los Angeles, CA USA
[15] Digest Hlth Associates Texas, Plano, TX USA
[16] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30851-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0646
引用
收藏
页码：S562 / S562
页数：1
相关论文
共 50 条
  • [21] Tenofovir disoproxil fumarate is not associated with a lower risk of hepatocellular carcinoma compared to entecavir in patients with chronic hepatitis B
    Lee, Hye Won
    Kim, Seung Up
    HEPATOMA RESEARCH, 2022, 8
  • [22] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    Wong, Grace Lai-Hung
    Han, Seungbong
    Lim, Young-Suk
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87
  • [23] Resolution of Hepatocellular Carcinoma in a Patient With Chronic Hepatitis B Treated With Entecavir Therapy
    Suri, Jaspreet
    Shah, Pir Ahmad
    Choudhry, Saad
    Nasser, Imad A.
    Lau, Daryl T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1239 - S1239
  • [24] Performance of Risk Estimation for Hepatocellular Carcinoma in Chronic Hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients
    Chen, T. -M.
    Chang, C. -C.
    Huang, P. -T.
    Wen, C. -F.
    Lin, C. -C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (02) : 243 - 251
  • [25] Entecavir reduces the incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Yasunaka, Tetsuya
    Ikeda, Fusao
    Takaki, Akinobu
    Seno, Tomonori
    Takaguchi, Koichi
    Yamamoto, Kazuhide
    HEPATOLOGY, 2014, 60 : 1096A - 1096A
  • [26] Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
    Lee, Jaemin
    Yoo, Sun Hong
    Sohn, Won
    Kim, Hyung Woo
    Choi, Yong Sun
    Won, Jung Ho
    Heo, Jin Young
    Park, Sang Jong
    Park, Young Min
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (03) : 339 - 349
  • [27] A comparative study of risks for hepatocellular carcinoma and mortality in chronic hepatitis B patients initially treated with entecavir or tenofovir
    Lee, Hyo Young
    Yoon, Eileen
    Jun, Dae Won
    Oh, Hyunwoo
    Ahn, Sang Bong
    Jeong, Jae Yoon
    Kim, Sung Eun
    Jeong, Soung Won
    Kim, Hyoung Su
    Shim, Jae-Jun
    Sohn, Joo Hyun
    Cho, Yong Kyun
    JOURNAL OF HEPATOLOGY, 2020, 73 : S593 - S594
  • [28] Use of tenofovir disoproxil fumarate is associated with a lower risk of hepatocellular carcinoma than entecavir in patients with chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    HEPATOMA RESEARCH, 2021, 7
  • [29] Antiviral Therapy for Chronic Hepatitis B (CHB) Reduces the Incidence of Hepatocellular Carcinoma (HCC) Regardless of Cirrhosis Status: Analysis with Adjustment for REACH-B Risk Score
    Lin, Derek
    Yang, Hwai-I
    Nguyen, Nghia H.
    Hoang, Joseph K.
    Kim, Yoona
    Vu, Vinh D.
    Le, An K.
    Chaung, Kevin T.
    Nguyen, Vincent G.
    Trinh, Huy N.
    Li, Jiayi
    Zhang, Jian Q.
    Hsing, Ann W.
    Chen, Chien-Jen
    Nguyen, Mindie H.
    HEPATOLOGY, 2015, 62 : 315A - 315A
  • [30] Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis
    Yuan, Bao-Hong
    Li, Ru-Hong
    Huo, Rong-Rui
    Li, Min-Jun
    Papatheodoridis, George
    Zhong, Jian-Hong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (05) : 782 - 794
12345